Annual report pursuant to Section 13 and 15(d)

Due To PAVmed Inc. (Tables)

v3.22.4
Due To PAVmed Inc. (Tables)
12 Months Ended
Dec. 31, 2022
Debt Disclosure [Abstract]  
Schedule of Senior Unsecured Promissory Note

The aggregate Due To: PAVmed Inc. for the periods indicated is summarized as follows:

 

    Principal Senior Unsecured Promissory Note     Interest Unsecured Senior Promissory Note     Working Capital Cash Advances     PAVmed Inc. OBO Payments    

Employee-

Related Costs

    MSA Fees     Total  
Balance - December 31, 2020   $     $     $ 8,200     $ 2,361     $     $ 2,700     $ 13,261  
MSA fees                                   3,630       3,630  
On Behalf Of (OBO) activities                 7,739       984                   8,723  
ERC - Payroll & Benefits                             1,037             1,037  
Promissory Note Issuance     22,400             (15,939 )     (2,411 )           (4,050 )      
Conversion of Promissory Note to LUCD Common Stock     (22,400 )                                   (22,400 )
Interest on Promissory Note           659                               659  
Cash payments to PAVmed Inc.           (659 )           (314 )           (2,280 )     (3,253 )
Balance - December 31, 2021   $     $     $     $ 620     $ 1,037     $     $ 1,657  

 

    CapNostics, LLC Transfer     PAVmed Inc. OBO Payments    

Employee-

Related Costs

    MSA Fees     Total  
Balance - December 31, 2021   $     $ 620     $ 1,037     $     $ 1,657  
MSA fees                       5,640       5,640  
On Behalf Of (OBO) activities           1,263                   1,263  
ERC - Payroll & Benefits                 10,204             10,204  
CapNostics, LLC transfer     2,105                         2,105  
Cash payments to PAVmed Inc.           (1,599 )     (5,495 )     (2,340 )     (9,434 )
Payment to PAVmed Inc. settled in LUCD stock   $ (2,105 )   $     $ (2,720 )   $ (1,650 )     (6,475 )
Balance - December 31, 2022   $     $ 284     $ 3,026     $ 1,650     $ 4,960